Skip to main content

HB Wealth Management, LLC

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1911253 Atlanta, GA

Position in AXSM

as of Mar 31, 2026 · filed Apr 27, 2026
Position Value
$8,491,057
+$2,262,668 QoQ
Shares Held
50,237
+47.3% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in AXSM Over Time

Shares Held

Position Value (USD)

Derivatives in AXSM

reported options exposure · as of Sep 30, 2025
CallValue
$0
CallShares
0
PutValue
$3,133,410
PutShares
25,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

HB Wealth Management, LLC holds $28,265,702 across 30 Biotechnology names. AXSM ranks #1 (30.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AXSM
Axsome Therapeutics, Inc.
This page
50,237 $8,491,057

All Filings in AXSM

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $8,491,057 50,237
2025-12-31 $6,228,389 34,102
2025-09-30 $4,883,018 40,206
2025-09-30 $3,133,410 25,800
2025-06-30 $2,599,311 24,900
2025-06-30 $2,603,486 24,940
2025-03-31 $6,418,148 55,030
2025-03-31 $2,904,087 24,900